A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors

Mansfield, AS; Hong, DS; Hann, CL; Farago, AF; Beltran, H; Waqar, SN; Hendifar, AE; Anthony, LB; Taylor, MH; Bryce, AH; Tagawa, ST; Lewis, K; Niu, JX; Chung, CEH; Cleary, JM; Rossi, M; Ludwig, C; Valenzuela, R; Luo, Y; Aggarwal, R

Aggarwal, R (corresponding author), UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.

NPJ PRECISION ONCOLOGY, 2021; 5 (1):

Abstract

Delta-like protein 3 (DLL3) is highly expressed in solid tumors, including neuroendocrine carcinomas/neuroendocrine tumors (NEC/NET). Rovalpituzumab t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索